Yuan-Chin Ivan Chang
Overview
Explore the profile of Yuan-Chin Ivan Chang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
117
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li C, Chiu Y, Chang C, Chang Y, Sheu J, Chiang A
Cancers (Basel)
. 2021 Jul;
13(13).
PMID: 34206705
Cervical squamous cell carcinoma (CESC) is one of the most common malignant tumors in women worldwide with a low survival rate. Acetyl coenzyme A synthase 2 (ACSS2) is a conserved...
2.
Chiang A, Li C, Tsui K, Chang C, Chang Y, Chen L, et al.
Biomolecules
. 2021 Jan;
11(1).
PMID: 33396624
Cervical cancer is a common gynecological malignancy, accounting for 10% of all gynecological cancers. Recently, targeted therapy for cervical cancer has shown unprecedented advantages. Several studies have shown that ubiquitin...
3.
Chen Z, Wang Z, Chang Y
Biometrics
. 2019 Oct;
76(2):496-507.
PMID: 31598956
Modeling correlated or highly stratified multiple-response data is a common data analysis task in many applications, such as those in large epidemiological studies or multisite cohort studies. The generalized estimating...
4.
Huang W, Chang Y
Pharm Stat
. 2018 May;
17(5):504-514.
PMID: 29722125
In pharmaceutical-related research, we usually use clinical trials methods to identify valuable treatments and compare their efficacy with that of a standard control therapy. Although clinical trials are essential for...
5.
Ke B, Chiang A, Chang Y
J Biopharm Stat
. 2017 Sep;
28(4):722-734.
PMID: 28920760
Classification measures play essential roles in the assessment and construction of classifiers. Hence, determining how to prevent these measures from being affected by individual observations has become an important problem....
6.
Shen S, Shen S, Liou T, Hsu M, Chang Y, Cheng C, et al.
Eur J Obstet Gynecol Reprod Biol
. 2015 Jul;
192:66-71.
PMID: 26177495
Objective: To evaluate the roles of obesity and inflammatory biomarkers associated with medical complications in women with PCOS. Study Design: Retrospective, BMI-matched study. A total of 330 patients, including 165...
7.
Yu W, Park E, Chang Y
J Biopharm Stat
. 2014 Jun;
25(5):881-902.
PMID: 24905904
The area under the receiver operating characteristic (ROC) curve (AUC) is a popularly used index when comparing two ROC curves. Statistical tests based on it for analyzing the difference have...
8.
Tzeng C, Chang Y, Chang Y, Wang C, Chen C, Hsu M
Fertil Steril
. 2014 Feb;
101(5):1404-10.
PMID: 24534286
Objective: To study the association between endocrine disturbances and metabolic complications in women seeking gynecologic care. Design: Retrospective study, cluster analysis. Setting: Outpatient clinic, university medical center. Patient(s): 573 women,...
9.
Hsu M, Chang Y, Hsueh H
BMC Res Notes
. 2014 Jan;
7:25.
PMID: 24410929
Background: A biomarker is usually used as a diagnostic or assessment tool in medical research. Finding an ideal biomarker is not easy and combining multiple biomarkers provides a promising alternative....
10.
Lin Y, Huang S, Hsu M, Chang Y, Cheng C, Hsu C, et al.
Eur J Obstet Gynecol Reprod Biol
. 2013 Oct;
171(2):314-8.
PMID: 24169034
Objective: Hyperhomocysteinaemia is a well-established risk factor for cardiovascular disease. This study investigated the relationship between hyperhomocysteinaemia and factors related to polycystic ovary syndrome (PCOS). Study Design: Case-control study. Three...